Pharmaceutical Industry
Pharmaceutical Industry
Pharmaceutical Industry
Industry
Prepared by
P.Srikanth Reddy
Table of
Contents
TOPICS COVERED
Chance / Risk
Firm strategy sructure and Rivalry
Factor Conditions
Demand Conditions
Related and Supporting Industries
Government
Chance /Risk
Increased Competition from Legal Liability for Opioid Product Liability Keeping Up with
Generic Drugs Addiction Beyond promoting competition
In 2017, the FDA began a push Technology
Opioid manufacturers are from generic drugs, the FDA is
to get lower-cost generic drugs also urging pharmaceutical
under fire for feeding the
out to market faster. Once a companies to cut down the cost
epidemic sweeping the nation. The study of human
new brand name drug is of new drugs by streamlining
Hundreds of lawsuits filed from genomics is paving the way
approved, it’s granted a 180-day and speeding up the research
the local to the federal level for personalized medicine, in
period of exclusivity, during and development process, which
accuse drug makers of which drugs are built to work
which time generic versions
misleading the public about the should eliminate some
cannot go to market. But, a with an individual’s unique
addictive properties of opioid overheard expenses.
backlog of generic applications set of genes, increasing their
painkillers. The suits While this makes drugs more
has stretched that 180 days effectiveness and safety. 3D
additionally allege that drug affordable for consumers, it
much longer. The FDA’s
makers exaggerating their also means medications spend
printers could emerge as top
renewed effort to clear that competitors for
benefits and urged doctors to less time in testing, increasing
backlog and get generic manufacturers; the first
over-prescribe for the sake of patient safety risk and
applications through the printed drug was approved by
increasing revenue. Now the regulatory risk.
approval process faster will
Department of Justice is getting the FDA in 2015.
flood the market with cheaper
involved. The explosion of personal
versions of high-cost drugs.
Attorney General Jeff Sessions Policy makers will weigh data collected by wearable
announced the creation of a access to medicines with the devices could enhance the
According to the FDA, the
task force to investigate desire to encourage
entree of two competitive quality of clinical studies and
manufacturers and distributors biopharmaceutical R&D, which
generic versions knocks down help researchers synthesize
of prescription opioids. He also relies on regulatory efforts to
the price of a brand name drug results more efficiently.
said the Department will streamline clinical research,
by 52 percent. The price falls
provide assistance to the ensure product quality, and
another 30 percent once nine
prosecution of lawsuits against achieve more efficient
generics are on the market.
the drug makers where it can. oversight.
About the
Logo
Symbols
and Lines
Presentations are
communication tools that
Meanings can be used as lectures.
BEUARAY CORP.
Zones
x x
Horizontal
BEUARAY Presentations are
CORP.
communication tools that
can be used as lectures.
Logo
Icon
Application
THE RULES ON
PROPER POSITIONING
DO NOT change the color. Use DO NOT crop the logo. DO NOT add shadows or effects.
only the colors in the palette.
Reminders
RULES ON LOGO USE TO KEEP IN MIND
DO NOT rotate the logo. DO NOT put over another DO NOT use tint or opacity.
illustration.
About
Beuaray Corp.
WWW.REALLYGREATSITE.COM